As our mouse study shows that NFIB clearly exhibits oncogenic function in SCLC, it will be critical to compare human primary tumors and metastases to determine whether human SCLC also exhibits increased NFIB expression in metastases. This evidence concerns the gene NFIB and small cell lung carcinoma.